MetaCap

POMDOCTOR LIMITED (POM) vs Scienture (SCNX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

POMDOCTOR LIMITED is the larger company by market cap ($7.3 million vs $6.3 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

POM-6.90%SCNX-6.54%
+0%-3%-7%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

POM versus SCNX key metrics
MetricPOMSCNX
Share price$0.7902$3.86
Market cap$7.32M$6.34M
1-day change-6.90%-6.54%
EPS (TTM)$-6.84$-52.75
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$115.74$65.00
52-week low$0.50$3.23
Distance from 52-week high-99.32%-94.06%
Analyst consensus—buy
Avg. price target upside—+871.50%
Average volume64.74K212.16K
Shares outstanding8.59M1.64M
Employees1654
SectorConsumer DiscretionaryHealth Care
IndustryOther Specialty StoresBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • The two companies sit in different sectors: POMDOCTOR LIMITED in Consumer Discretionary and Scienture in Health Care.

About POMDOCTOR LIMITED

POM stock →

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China.

Consumer Discretionary · Other Specialty Stores · 165 employees

About Scienture

SCNX stock →

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees

POM vs SCNX FAQ

Which is bigger, POMDOCTOR LIMITED or Scienture?

POMDOCTOR LIMITED (POM) is larger, with a market capitalization of $7.32M compared with $6.34M for Scienture (SCNX).

Are POMDOCTOR LIMITED and Scienture in the same industry?

No. POMDOCTOR LIMITED is in the Consumer Discretionary sector, while Scienture is in Health Care.

More comparisons